Scientists may be able to turn a long-time germ foe into a cancer-fighting ally, new research this week suggests. In preliminary data from a Phase I trial, a genetically modified version of the herpes virus has shown promise in treating difficult-to-eradicate tumors, with one patient having experienced a complete...
Scientists may be able to turn a long-time germ foe into a cancer-fighting ally, new research this week suggests. In preliminary data from a Phase I trial, a genetically modified version of the herpes virus has shown promise in treating difficult-to-eradicate tumors, with one patient having experienced a complete...
Share this Article
Recommended